pharma · Complement-mediated Hemolytic Diseases
Nanjing Chia-tai Tianqing
Nanjing Chia-tai Tianqing Pharmaceutical
Nanjing Chia-tai Tianqing clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Nanjing Chia-tai Tianqing projects
1 ClinicalTrials.gov programs sponsored by Nanjing Chia-tai Tianqing.
Nanjing Chia-tai Tianqing has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Nanjing Chia-tai Tianqing have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.